1. Home
  2. EMBC vs XYF Comparison

EMBC vs XYF Comparison

Compare EMBC & XYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMBC
  • XYF
  • Stock Information
  • Founded
  • EMBC 1924
  • XYF 2014
  • Country
  • EMBC United States
  • XYF China
  • Employees
  • EMBC N/A
  • XYF N/A
  • Industry
  • EMBC Medical/Dental Instruments
  • XYF Finance: Consumer Services
  • Sector
  • EMBC Health Care
  • XYF Finance
  • Exchange
  • EMBC Nasdaq
  • XYF Nasdaq
  • Market Cap
  • EMBC 803.0M
  • XYF 708.7M
  • IPO Year
  • EMBC N/A
  • XYF 2018
  • Fundamental
  • Price
  • EMBC $14.50
  • XYF $7.41
  • Analyst Decision
  • EMBC Buy
  • XYF
  • Analyst Count
  • EMBC 2
  • XYF 0
  • Target Price
  • EMBC $18.50
  • XYF N/A
  • AVG Volume (30 Days)
  • EMBC 374.6K
  • XYF 253.9K
  • Earning Date
  • EMBC 11-25-2025
  • XYF 11-20-2025
  • Dividend Yield
  • EMBC 4.15%
  • XYF 1.07%
  • EPS Growth
  • EMBC 18.26
  • XYF 49.84
  • EPS
  • EMBC 1.42
  • XYF 5.72
  • Revenue
  • EMBC $1,102,500,000.00
  • XYF $1,106,908,607.00
  • Revenue This Year
  • EMBC N/A
  • XYF N/A
  • Revenue Next Year
  • EMBC N/A
  • XYF N/A
  • P/E Ratio
  • EMBC $10.18
  • XYF $1.34
  • Revenue Growth
  • EMBC N/A
  • XYF 47.14
  • 52 Week Low
  • EMBC $9.20
  • XYF $6.31
  • 52 Week High
  • EMBC $21.48
  • XYF $20.36
  • Technical
  • Relative Strength Index (RSI)
  • EMBC 56.37
  • XYF 12.84
  • Support Level
  • EMBC $13.61
  • XYF $11.86
  • Resistance Level
  • EMBC $14.81
  • XYF $12.57
  • Average True Range (ATR)
  • EMBC 0.62
  • XYF 0.62
  • MACD
  • EMBC 0.05
  • XYF -0.44
  • Stochastic Oscillator
  • EMBC 75.16
  • XYF 3.44

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About XYF X Financial each representing six

X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.

Share on Social Networks: